StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular r&d expenses

Research and development expenses are spending on new products and technology.

LeMaitre Vascular's R&D Expenses for the twelve months ending Jun 30, 2026 was $15.41M, up 3.4% year over year. For fiscal 2025 it was $14.14M, down 9.7% from the year before. Over ten years it grew 9.9% a year on average. The highest annual figure on record is $16.97M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.14M-9.7%
FY2024Dec 31, 2024$15.65M-7.8%
FY2023Dec 31, 2023$16.97M+27.6%
FY2022Dec 31, 2022$13.29M+12.7%
FY2021Dec 31, 2021$11.80M+16.9%
FY2020Dec 31, 2020$10.10M+8.9%
FY2019Dec 31, 2019$9.28M+13.2%
FY2018Dec 31, 2018$8.20M+23.5%
FY2017Dec 31, 2017$6.64M+8.1%
FY2016Dec 31, 2016$6.14M+12.1%
FY2015Dec 31, 2015$5.48M+17.3%
FY2014Dec 31, 2014$4.67M-10.9%
FY2013Dec 31, 2013$5.24M+3.0%
FY2012Dec 31, 2012$5.09M+15.1%
FY2011Dec 31, 2011$4.43M-19.4%
FY2010Dec 31, 2010$5.49M-7.1%
FY2009Dec 31, 2009$5.91M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.85M+36.9%
Q1 FY2026Mar 31, 2026$4.06M-0.9%
Q4 FY2025Dec 31, 2025$3.53M-2.3%
Q3 FY2025Sep 30, 2025$2.97M-18.8%
Q2 FY2025Jun 30, 2025$3.54M-17.3%
Q1 FY2025Mar 31, 2025$4.10M+0.1%
Q4 FY2024Dec 31, 2024$3.62M-16.8%
Q3 FY2024Sep 30, 2024$3.66M-13.4%
Q2 FY2024Jun 30, 2024$4.28M-5.1%
Q1 FY2024Mar 31, 2024$4.09M+5.6%
Q4 FY2023Dec 31, 2023$4.35M+22.4%
Q3 FY2023Sep 30, 2023$4.22M+22.0%
Q2 FY2023Jun 30, 2023$4.52M+35.0%
Q1 FY2023Mar 31, 2023$3.88M+32.2%
Q4 FY2022Dec 31, 2022$3.55M+2.8%
Q3 FY2022Sep 30, 2022$3.46M+21.6%
Q2 FY2022Jun 30, 2022$3.35M+26.2%
Q1 FY2022Mar 31, 2022$2.93M+3.1%
Q4 FY2021Dec 31, 2021$3.46M+20.5%
Q3 FY2021Sep 30, 2021$2.85M+35.7%
Q2 FY2021Jun 30, 2021$2.65M+24.0%
Q1 FY2021Mar 31, 2021$2.84M-5.0%
Q4 FY2020Dec 31, 2020$2.87M+14.8%
Q3 FY2020Sep 30, 2020$2.10M-8.0%
Q2 FY2020Jun 30, 2020$2.14M-5.2%
Q1 FY2020Mar 31, 2020$2.99M+33.7%
Q4 FY2019Dec 31, 2019$2.50M+6.5%
Q3 FY2019Sep 30, 2019$2.28M+12.0%
Q2 FY2019Jun 30, 2019$2.26M+13.5%
Q1 FY2019Mar 31, 2019$2.24M+22.7%
Q4 FY2018Dec 31, 2018$2.35M+48.3%
Q3 FY2018Sep 30, 2018$2.04M+15.7%
Q2 FY2018Jun 30, 2018$1.99M+21.7%
Q1 FY2018Mar 31, 2018$1.83M+10.1%
Q4 FY2017Dec 31, 2017$1.58M+4.0%
Q3 FY2017Sep 30, 2017$1.76M+14.4%
Q2 FY2017Jun 30, 2017$1.63M–
Q1 FY2017Mar 31, 2017$1.66M–
Q4 FY2016Dec 31, 2016$1.52M–
Q3 FY2016Sep 30, 2016$1.54M–

More LeMaitre Vascular figures

See a number that looks wrong?